Myeloablative Doses of Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation in Non-Hodgkin'S Lymphoma
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2011.12.240
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2012
Authors
Publisher
Elsevier BV